☰

Sarah Barelier - Publications

Affiliations: 
2013- Chemistry University of California, San Francisco, San Francisco, CA 
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Barelier S, Sterling T, O'Meara MJ, Shoichet BK. The Recognition of Identical Ligands by Unrelated Proteins. Acs Chemical Biology. PMID 26421501 DOI: 10.1021/Acschembio.5B00683  0.631
2014 Barelier S, Eidam O, Fish I, Hollander J, Figaroa F, Nachane R, Irwin JJ, Shoichet BK, Siegal G. Increasing chemical space coverage by combining empirical and computational fragment screens. Acs Chemical Biology. 9: 1528-35. PMID 24807704 DOI: 10.1021/Cb5001636  0.545
2014 Barelier S, Cummings JA, Rauwerdink AM, Hitchcock DS, Farelli JD, Almo SC, Raushel FM, Allen KN, Shoichet BK. Substrate deconstruction and the nonadditivity of enzyme recognition. Journal of the American Chemical Society. 136: 7374-82. PMID 24791931 DOI: 10.1021/Ja501354Q  0.529
2013 Barelier S, Boyce SE, Fish I, Fischer M, Goodin DB, Shoichet BK. Roles for ordered and bulk solvent in ligand recognition and docking in two related cavities. Plos One. 8: e69153. PMID 23874896 DOI: 10.1371/Journal.Pone.0069153  0.534
2012 Eidam O, Romagnoli C, Dalmasso G, Barelier S, Caselli E, Bonnet R, Shoichet BK, Prati F. Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo. Proceedings of the National Academy of Sciences of the United States of America. 109: 17448-53. PMID 23043117 DOI: 10.1073/Pnas.1208337109  0.507
2011 Barelier S, Krimm I. Ligand specificity, privileged substructures and protein druggability from fragment-based screening. Current Opinion in Chemical Biology. 15: 469-74. PMID 21411360 DOI: 10.1016/J.Cbpa.2011.02.020  0.424
2010 Barelier S, Pons J, Gehring K, Lancelin JM, Krimm I. Ligand specificity in fragment-based drug design. Journal of Medicinal Chemistry. 53: 5256-66. PMID 20575554 DOI: 10.1021/Jm100496J  0.56
2010 Barelier S, Linard D, Pons J, Clippe A, Knoops B, Lancelin JM, Krimm I. Discovery of fragment molecules that bind the human peroxiredoxin 5 active site. Plos One. 5: e9744. PMID 20305821 DOI: 10.1371/Journal.Pone.0009744  0.607
2010 Barelier S, Pons J, Marcillat O, Lancelin JM, Krimm I. Fragment-based deconstruction of Bcl-xL inhibitors. Journal of Medicinal Chemistry. 53: 2577-88. PMID 20192224 DOI: 10.1021/Jm100009Z  0.588
Show low-probability matches.